Physician

Julia Moukharskaya, MD

According to 2025 Medicare claims, Julia Moukharskaya, MD (NPI: 1730341702) practices hematology/oncology in the Lewiston-Auburn, ME market, with the plurality of this provider's patient population coming from Androscoggin, ME. This provider's primary affiliated billing organization is CENTRAL MAINE MEDICAL CENTER (NPI: 1689653487; TIN: 010211494) and primary practice location at 04240-7614. Moukharskaya is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), participating under the MSSP model.

Moukharskaya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 163 traditional Medicare patients, billed 455 HCPCS/CPT codes, and received $38,844 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 857 prescription claims across 258 beneficiaries totaling $1,865,304 in drug costs, led by Brukinsa (Zanubrutinib). DME data shows 85 claims. Open Payments data shows 8 records totaling $179. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $39,778 to $38,844. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $757,920 to $1,865,304. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,495 and ending at $7,120.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	207	672	$39,778
2016	316	1,053	$62,274
2017	440	1,271	$71,779
2018	470	1,114	$66,040
2019	411	1,431	$93,260
2020	415	1,431	$85,150
2021	491	1,535	$110,437
2022	366	72,182	$1,222,005
2023	282	94,774	$1,583,792
2024	163	455	$38,844

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	137	890	$757,920
2016	166	1,008	$871,051
2017	165	1,068	$1,715,383
2018	181	792	$1,041,048
2019	184	885	$1,144,581
2020	204	1,192	$1,627,708
2021	236	1,401	$3,016,452
2022	235	694	$1,420,764
2023	213	1,039	$2,986,076
2024	258	857	$1,865,304

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	132	$33,047
2016	N/R	84	$4,675
2017	N/R	87	$10,127
2018	N/R	171	$6,523
2019	N/R	102	$10,252
2020	N/R	51	$3,592
2021	N/R	50	$3,593
2022	N/R	30	$1,152
2023	N/R	N/R	N/R
2024	N/R	85	$7,910

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	40	40	$141
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	56	95	$113
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	21	21	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	99	215	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	46	62	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	22	660	$333,338
Verzenio	Abemaciclib	18	455	$222,423
Sprycel	Dasatinib	12	360	$205,819
Ibrance	Palbociclib	12	336	$196,423
Lenalidomide	Lenalidomide	13	364	$194,483

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	17	$3,769
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	34	$3,214
J9190	Injection, fluorouracil, 500 mg	N	N/R	34	$927

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$179	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Julia Moukharskaya, MD?

Tedicare shows public-source Medicare data for Julia Moukharskaya, MD (NPI 1730341702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julia Moukharskaya, MD have ACO affiliation data?

Julia Moukharskaya, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290).

What billing organization is linked to Julia Moukharskaya, MD?

Julia Moukharskaya, MD is linked to CENTRAL MAINE MEDICAL CENTER (billing NPI 1689653487) in the available physician profile data.

Does Julia Moukharskaya, MD have Open Payments data?

Julia Moukharskaya, MD has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.